AAC and Insurance: Getting Device Coverage
The documentation that gets AAC devices funded, the medical necessity letter that does most of the work, the trial period that demonstrates use, and the appeal pathway when the first denial arrives.
1
One well-built medical necessity letter does most of the work. The SLP signs it, the family assembles the evidence, approval rates climb. The letter is the assignment.
A qualified speech-language pathologist conducts the AAC evaluation. The evaluation is the foundation of the funding request.
Diagnosis, functional impact, prior approaches tried, devices considered, recommendation. Specific, clinical, supported.
Most initial denials are reversed at the first level of appeal when documentation gaps are addressed. Plan for appeal as part of the process.
Schedule the SLP evaluation this week. The letter starts there.
The medical necessity letter is signed by the SLP based on the evaluation. Without the evaluation, no letter; without the letter, no funding. The evaluation can run a six-week wait in some regions. The call is the assignment, even if the appointment is two months out. Use the wait to assemble the supporting documentation the SLP will need: prior communication tools tried, current communication failures, daily-life impact examples.
The “tried and failed” denial
Insurance commonly denies AAC saying other communication approaches have not been tried and failed. Documentation that preempts this specifically is the difference between approved and denied.
Medical necessity letter
SLP-signed, two to three pages, addresses each anticipated denial reason. The letter is the brief. The brief is the case. Everything else is supporting evidence.
Trial period
Most insurance plans require or allow a trial period with the proposed device. The trial is evidence. The trial is also where the family learns what they actually need.
Approval timeline
Submission to approval typically 30-60 days. Submission to denial often faster. Denial through successful appeal, three to six months total. Plan the calendar.
Required documentation
Diagnosis, functional communication evaluation, prior approaches with outcomes, recommended device, expected outcomes, prescriber sign-off.
Appeal pathway
First-level appeal usually within 60 days of denial. Add the missing documentation. Address the specific denial reason. Reversal rates are meaningful when the letter is rewritten well.
What goes in the medical necessity letter
The first denial said my son had not tried alternatives. He had been using picture cards for eight years. The SLP rewrote the medical necessity letter to specifically list each prior method, dates, and why each was insufficient. The appeal was approved in nineteen days. The device arrived a week later. He has been using it for three years. The total time from first call to device-in-hand was four and a half months. The denial was a step in the process, not the end of it.
Building the funding application
- Schedule the SLP evaluation. Confirm the SLP has worked with adult AAC funding before.
- Request the evaluation report in writing, with specific functional impact descriptions.
- Draft the medical necessity letter with the SLP. Address common denial reasons preemptively.
- Submit through the prescriber’s office or the device vendor’s funding department, whichever the SLP recommends.
- If denied, appeal within the deadline. The appeal is not a setback; it is the second step of the process.
- SLP with adult AAC funding experience identified
- Evaluation completed and report received
- Medical necessity letter drafted
- Insurance plan policy reviewed
- Submission method confirmed (vendor vs. prescriber)
- Calendar entry for appeal deadline (typically 60 days)
- Backup low-tech communication in place during wait
Insurance does not reward the family who gives up at the first denial. Insurance rewards the family that appeals. Plan for both.
The full story · For readers who want context
Vera’s first AAC funding application for her adult son came back denied in twenty-eight days. The denial letter, on the insurance company’s letterhead, said the applicant had not tried and failed alternative communication approaches. Vera’s son had been using picture cards for eight years, structured by an SLP at his county service program. He had aged out of that program at twenty-two and now had a Medicaid managed-care plan that handled AAC funding differently than the prior children’s program had. The denial was correct in the sense that the application had not specifically documented the picture-card years. The denial was incorrect in the sense that those years existed and were extensively documented elsewhere. Vera’s new SLP rewrote the medical necessity letter to list, with dates, every prior communication tool, every functional context in which it had been used, and the specific ways each had reached its ceiling. The appeal was approved in nineteen days. The device arrived a week later. Vera’s son has been using it for three years. The total time from her first call to a device in his hand was four and a half months. The denial was not the end of the process. The denial was the second step.
The funding pathway, in three layers.
Here is what they will not tell you on the front of any AAC vendor’s brochure. The funding pathway for an AAC device runs through three layers, each of which has its own requirements and its own failure modes. The first layer is the SLP evaluation: a qualified speech-language pathologist assesses the adult, identifies the communication needs, evaluates candidate devices, and produces a written report. The second layer is the medical necessity documentation: a letter, usually signed by the SLP and sometimes also by a physician, that frames the device as medically necessary under the specific insurance plan’s coverage criteria. The third layer is the submission and adjudication: the funding request goes to the insurance plan (or Medicaid managed care organization, or fee-for-service Medicaid), gets reviewed, and is either approved or denied.
Approval rates for properly documented AAC funding requests are substantially higher than most families assume. Industry estimates from vendors and from the Speech-Language and Hearing Association suggest that initial approvals run in the high-fifties to mid-sixties percent range, and that successful appeals after first denial bring eventual approval rates above eighty percent. The variance across plans is large; some Medicaid programs approve at ninety-plus percent on first submission with adequate documentation; some commercial plans approve at a much lower initial rate but reverse on first appeal at high rates. Verify these figures against your specific plan and current Medicaid policy before relying on them as precise; the direction is consistent in the literature even when the specific percentages drift year to year.
Why the medical necessity letter does the work.
The medical necessity letter is the document that translates the SLP evaluation into the language the insurance reviewer reads. A good letter is two to three pages. It states the patient identification clearly. It describes the diagnosis with the relevant ICD codes. It documents functional communication impacts in concrete daily-life terms (“the patient cannot reliably communicate pain location during medical encounters; this resulted in three emergency department visits in the past year that could have been managed at the primary-care level with adequate communication”). It lists prior communication approaches that have been tried, with approximate dates and reasons each has reached its limit. It recommends a specific device by make and model, with clinical rationale. It anticipates the most common denial reasons and addresses them preemptively.
The “tried and failed” denial and how to preempt it.
The single most common AAC denial reason is some version of “patient has not adequately tried alternative communication methods.” The denial is generic and frequently uses boilerplate language; it appears on denials whether or not prior methods were actually tried, because the reviewer often does not know what was tried. The remedy is to include the prior-trial documentation directly in the letter rather than waiting for the reviewer to ask. List each prior method (picture cards, sign approximations, gestural communication, low-tech communication books, prior AAC apps or devices that were inadequate). Provide approximate dates of use. Describe the specific limitations of each.
If the adult is just starting AAC and has not formally tried prior methods, document what natural communication has been tried (gestures, vocalizations, written notes) and where each has reached its limit. The point is to show that AAC is being considered as the next appropriate step rather than as a first untested approach. Insurance reviewers respond to clinical reasoning, not to advocacy intensity. The letter is the clinical reasoning.
The trial period as evidence.
Most insurance plans allow or require a trial period with the proposed device before final approval. The trial period serves two functions. It demonstrates that the patient can use the device productively, which addresses the medical necessity question. It also surfaces practical issues the family had not anticipated (the specific vocabulary needed, the screen-size that actually works, the mounting or carrying solution that fits the adult’s daily life). The trial is evidence in the funding pathway and is also information for the family.
Vendor-supplied trial devices are typical. Most major AAC vendors (Tobii Dynavox, PRC-Saltillo, AbleNet, Forbes AAC) provide trial devices for two to four weeks at no charge, with vendor staff supporting the configuration. The SLP supervises the trial and documents the outcomes. The trial documentation goes into the funding application as supporting evidence. The trial often makes the difference in the funding approval, particularly for first-time AAC users where the question of “will the patient use it” is most acute.
The first appeal is part of the process.
Treat the first denial as a step rather than a setback. Most initial denials are reversed at the first level of appeal when the documentation gaps are addressed specifically. The first level of appeal is usually a paper review by a different reviewer at the same insurance plan. The deadline is typically sixty days from the denial date. The appeal letter should specifically address the denial reason given, supply the missing documentation, and request reconsideration.
If the first appeal is also denied, the second level of appeal often involves a peer-to-peer review (the prescribing clinician or SLP speaks with a clinical reviewer at the insurance plan) or a state-level external review. External reviews, particularly for Medicaid plans, frequently reverse insurance denials when the medical necessity is clear. The state insurance commissioner (for commercial plans) and the state Medicaid director’s office (for Medicaid managed care plans) maintain external review pathways that families and clinicians can invoke.
Vendor-led vs. prescriber-led submissions.
AAC device vendors offer funding-application support as part of their sales process. The vendor’s funding team handles the paperwork, files the application, manages the appeals, and ships the device on approval. The service is often included in the device cost. The benefit is operational convenience; the family does less paperwork. The cost is a structural conflict of interest: the vendor’s funding team has an incentive to recommend the vendor’s device.
Prescriber-led submissions are handled through the physician’s or SLP’s office directly. The clinic writes the medical necessity letter, files the application, and tracks the response. The family is more involved in the paperwork. The benefit is independence from any specific vendor; the SLP can recommend the best device for the patient regardless of which vendor’s funding team would otherwise handle the application. The cost is more operational work for the family.
Either approach can produce a good outcome. The choice depends on the SLP’s confidence in the device recommendation, the family’s bandwidth for paperwork, and whether the SLP has an established relationship with a specific vendor’s funding team. Ask the SLP which approach they recommend for the specific funding source.
What other states make easier.
Several state Medicaid programs publish clear AAC coverage policies with documentation templates and decision criteria (Massachusetts, Pennsylvania, Tennessee, California). Several state assistive technology programs maintain funding-navigation support for families through the AT Act program. The Communication First organization, run by AAC users themselves, publishes plain-language funding guides. AAC industry associations including USSAAC (the United States Society for Augmentative and Alternative Communication) maintain funding resources and clinician directories. Michigan covers AAC under Medicaid and many private plans, but with less coordinated state-level funding-navigation infrastructure than peer states. Other states made different choices. Michigan didn’t, fully.
Your assignment this week.
This week: schedule the SLP evaluation if not done. Identify the insurance plan or Medicaid managed-care organization, request a copy of their AAC coverage policy in writing, and read it before the medical necessity letter is drafted. Within thirty days: the evaluation report. Within sixty days: the medical necessity letter and submission. Within ninety to one hundred eighty days: approval or first appeal. Other states make this faster with policy-publication transparency and AT navigators. Michigan didn’t, fully. Now we know what we are fighting. Together.